How can the personal discovery process evolve personalized medicine? An interview with Laura Towart

A Towart (2019) How can the personal discovery process evolve personalized medicine? An interview with Laura Towart Per Med (IF: 2.3) 16(6) 435-437

Abstract

Laura is the Founder and CEO of My Personal Therapeutics, a London-based digital health company offering the most advanced personalized cancer therapeutics. She is also the Founder and former CEO of Celmatix, a leader in diagnostics and predictive analytics for female infertility and women's health. She is a graduate of the Weill Cornell Graduate School of Medical Sciences and Memorial Sloan Kettering Cancer Center's Doctoral program and received a Certificate in Bioinformatics. She holds a BS/BA in Biology/English from The George Washington University. Besides being passionate about personalized medicine, she enjoys exploring the world with her children Julian, Valentina and Delphine.

Links

http://www.ncbi.nlm.nih.gov/pubmed/31516077
http://dx.doi.org/10.2217/pme-2019-0087

Similar articles

Tools